Goldman Sachs’s Nuvectis Pharma NVCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-45,608	Closed	-$446K	–	5301
2025 Q1	$446K	Buy	+45,608	New	+$446K	﹤0.01%	4316
2024 Q3	–	Sell	-61,570	Closed	-$390K	–	4954
2024 Q2	$390K	Buy	+61,570	New	+$390K	﹤0.01%	4082